Year: 2025
Type: article
Study design: Case Report
Abstract: This case report highlights the importance of recognizing potential pitfalls in HbA1c measurement errors and being vigilant in terms of discrepancies between HbA1c estimated from continuous glucose monitoring (CGM) and venous HbA1c measurements. The latter is especially relevant for physicians managing diabetes, as by 2025, 4,400 adults with insulin-treated type 2 diabetes are expected to start using CGM devices, many of whom will be monitored in primary care settings.
Source: Ugeskrift for Læger
DOI: 10.61409/v12240902
Authors: Mads Bisgaard Bengtsen, Esben Søndergaard
Institutions: Aarhus University Hospital, Steno Diabetes Center Aarhus
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4411462192